Regeneron Pharmaceuticals
REGN
Reported
Thursday, October 31
Q3 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | 11.7 | 12.5 | 0.77 | 6.59% |
| Revenue | 3.67B | 3.72B | 51.0M | 1.39% |
WhatIF - Earnings
EPS Beat Expectations by $0.77
Regeneron Pharmaceuticals (REGN:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything